Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 5Terminated 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 6Sarcoma 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 395Neoplasms 350Carcinoma, Non-Small-Cell Lung 313Prostatic Neoplasms 264Colorectal Neoplasms 236Lung Neoplasms 204Multiple Myeloma 163Pancreatic Neoplasms 147Ovarian Neoplasms 146Neoplasm Metastasis 141Leukemia, Myeloid, Acute 138Melanoma 118Squamous Cell Carcinoma of Head and Neck 100Carcinoma, Renal Cell 93Stomach Neoplasms 92Recurrence 92Lymphoma 91Lymphoma, Non-Hodgkin 89Endometrial Neoplasms 89Carcinoma, Hepatocellular 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 87Glioblastoma 85Brain Neoplasms 84Head and Neck Neoplasms 77Glioma 76Uterine Cervical Neoplasms 75Urinary Bladder Neoplasms 72Sarcoma 70Leukemia, Lymphocytic, Chronic, B-Cell 70Hematologic Neoplasms 68

Interventions

trifluridine tipiracil drug combination 1obeticholic acid 1Specimen Handling 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Exercise Therapy 1Endoscopy, Gastrointestinal 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × 30 days × Clear all
NCT05552755 2026-06-05

TUPELO

Recursion Pharmaceuticals Inc.

Phase 1/2 Recruiting
67 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT06950385 2026-06-02

SERENTA

Rapamycin Holdings Inc.

Phase 3 Recruiting
168 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Polyps

NCT05919264 2026-05-28

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Parabilis Medicines, Inc.

Phase 1/2 Recruiting
595 enrolled
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Craniopharyngioma, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Desmoid Tumors

NCT06614738 2026-05-27

Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)

Hospices Civils de Lyon

Recruiting
100 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT06641310 2026-05-19

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

University of Michigan Rogel Cancer Center

Phase NA Recruiting
32 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡